Comparative Pharmacology
Head-to-head clinical analysis: DICYCLOMINE HYDROCHLORIDE versus GLYRX PF.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DICYCLOMINE HYDROCHLORIDE versus GLYRX PF.
DICYCLOMINE HYDROCHLORIDE vs GLYRX-PF
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of muscarinic acetylcholine receptors, inhibiting parasympathetic nerve impulses in the gastrointestinal tract, leading to smooth muscle relaxation.
Glycopyrrolate is a quaternary ammonium anticholinergic that inhibits muscarinic acetylcholine receptors, thereby reducing salivary secretion and blocking vagally mediated bronchoconstriction.
10-20 mg orally 3-4 times daily
Intravenous: 1 mg/kg of ideal body weight for 2 minutes, repeated in 2 hours if required; thereafter every 4 hours as needed.
None Documented
None Documented
1.8 to 2.5 hours (terminal half-life, shorter in younger patients)
Terminal elimination half-life of 4-6 hours; prolonged to 10-12 hours in renal impairment.
Renal (∼79.5% as unchanged drug and metabolites) with minor biliary/fecal elimination (∼8-10%)
Primarily renal excretion of unchanged drug (70-80%) and metabolites; minor biliary excretion (<10%).
Category A/B
Category C
Anticholinergic
Anticholinergic